Investigational Site Number 7100001

Parow 7500

0 studies enrolling now · 2 studies all time

What they study most

Chronic Kidney Diseases, Heart Failure, Hypercholesterolaemia, Type 2 Diabetes Mellitus

Studies at this site

• Effect of Sotagliflozin on Cardiovascular and Renal Events in Participants With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk — Stopped early
• An 8-Week Dose-Finding Study to Evaluate the Efficacy and Safety of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia — Completed